Modern hypnosis can be traced back to the 18th century and during this period mesmerism, as it was then known, was a healing practice which spread throughout Europe and North America. Since then hypnosis has been treated primarily as a psychological phenomenon and theories about hypnosis are grounded in mainstream psychology and its related disciplines. Most recently it has been subject to extensive clinical trials to investigate its therapeutic effectiveness. In their comprehensive introduction to this invaluable collection the editors trace the historical development of hypnosis, providing an excellent review of the theories that have tried to explain how hypnosis works and reflecting on the cultural and scientific attitudes and practices that prevailed at various times. They have selected the most important previously published papers that reveal how a scientific approach to understanding hypnosis as a psychological phenomenon has emerged over the last 70 years. They have also included a selection of reports on clinical applications and on legal and forensic issues. As such this volume will prove an invaluable reference resource for researchers and students already in the field and new scholars interested in learning more about hypnosis.

Irving Kirsch has the world doubting the efficacy of antidepressants. Based on fifteen years of research, The Emperor's New Drugs makes an overwhelming case that what the medical community considered a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: He offers a path society can follow to stop popping pills and start proper treatment.

Everyone knows that antidepressant drugs are miracles of modern medicine. Professor Irving Kirsch knew this as well as anyone. But, as he discovered during his research, there is a problem with what everyone knows about antidepressant drugs. It isn't true. How did antidepressant drugs gain their reputation as a magic bullet for depression? And why has it taken so long for the story to become public? Answering these questions takes us to the point where the lines between clinical research and marketing disappear altogether. Using the Freedom of Information Act, Kirsch accessed clinical trials that were withheld, by drug companies, from the public and from the doctors who prescribe antidepressants. What he found, and what he documents here, promises to bring revolutionary change to the way our society perceives, and consumes, antidepressants. The Emperor's New Drugs exposes what we have failed to see before: depression is not caused by a chemical imbalance in the brain; antidepressants are significantly more dangerous than other forms of treatment and are only marginally more effective than placebos; and, there are other ways to combat depression, treatments that don't only include the empty promise of the antidepressant prescription. This is not a book about alternative medicine and its outlandish claims. This is a book about fantasy and wishful thinking in the heart of clinical medicine, about the seductions of myth, and the final stubbornness of facts.